Abbott Navica Administrator Apps User Guide

June 4, 2024
APPs

QUICK REFERENCE GUIDE

NAVICA™
ADMINISTRATOR

Perform the BinaxNOW™ COVID-19 Ag Cardtest and communicate encrypted test results using the NAVICA™ Administrator App.

Abbott Navica Administrator Apps

  1. Log in to the NAVICA™ Administrator App, and select Begin New Test.
    Abbott Navica Administrator Apps - app 1

  2. Scan the participant’s unique NOVICA ID QR code using the camera on your tablet.
    Abbott Navica Administrator Apps - app 2

  3. Verify the participant’s identity with a photo ID.

  4. Scan the BinaxNOW™ COVID-19 Ag Card QR code to link the participant’s NOVICA ID to the test card.
    Abbott Navica Administrator Apps - app 4

  5. Collect the nasal swab and perform the test.
    (See the BinaxNOW™ COVID-19 Ag Card Product Insert, including the quality control section, for complete use instructions, warnings, precautions and limitations.)
    Abbott Navica Administrator Apps - app 5

  6. To enter the result into the NAVICA™ Administrator App, rescan the QR code on the test card to confirm the link between the test and the participant.
    Abbott Navica Administrator Apps - app 6

  7. Visually interpret the results on the test card and enter the results in the NOVICA Administrator App with a single tap.
    Abbott Navica Administrator Apps - app 7

THE PARTICIPANT WILL RECEIVE A PUSH NOTIFICATION AND BE NOTIFIED VIA EMAIL TO REVIEW THEIR ENCRYPTED RESULT IN THE NAVICA APP.
YOUR FAC ILITY WILL SEPARATELY NOTIFY THE PARTICIPANT VIA YOUR REGULAR PROCESS FOR LAB TEST REPORTING.

The BinaxNOW™ COVID-19 Ag Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under
Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
© 2020 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. COL-02303 V2 12/21

Read User Manual Online (PDF format)

Read User Manual Online (PDF format)  >>

Download This Manual (PDF format)

Download this manual  >>

Related Manuals